Stoke Therapeutics (STOK) FCF Margin (2022 - 2026)
Stoke Therapeutics (STOK) posted quarterly FCF Margin of 978.25% for Q1 2026, down 106137.0% year-over-year from N/an in Q1 2025, and up 55.8% quarter-over-quarter from 2213.41% in Q4 2025.
Stoke Therapeutics (STOK) FCF Margin (2022 - 2026) Analysis & Trends
Stoke Therapeutics' FCF Margin history runs 5 years deep, the most recent figure standing at 978.25% for Q1 2026.
- In Q1 2026, FCF Margin fell 106137.0% year-over-year to 978.25%; the TTM figure through Mar 2026 stood at 460.79% (down 49710.0% YoY), while the FY2025 annual figure was 24.35%, up 26250.0% from the prior year.
- FCF Margin for Q1 2026 stood at 978.25%, up from 2213.41% in the prior quarter.
- The five-year high for FCF Margin was 1055.0% in Q1 2022, with the low at 2213.41% in Q4 2025.
- The 5-year median for FCF Margin is 533.4% (2023), against an average of 509.38%.
- Peak annual rise in FCF Margin reached 66595 bps in 2025, while the deepest fall reached 211000 bps in 2025.
- Stoke Therapeutics' FCF Margin stood at 675.89% in 2022, then retreated by 10 bps to 745.11% in 2023, then jumped by 86 bps to 103.41% in 2024, then sank by 2040 bps to 2213.41% in 2025, then jumped by 56 bps to 978.25% in 2026.
- Business Quant data shows STOK's FCF Margin at 978.25% in Q1 2026, 2213.41% in Q4 2025, and 286.0% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,594.17% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 70.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.62% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.35% |
| 10 | Stoke Therapeutics | 1.95 Bn | 1.66 Bn | - | -628.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -628.00% |
| Mar 31, 2026 | -978.25% |
| Dec 31, 2025 | -2,213.41% |
| Sep 30, 2025 | -286.00% |
| Jun 30, 2025 | -184.16% |
| Mar 31, 2025 | 83.12% |
| Dec 31, 2024 | -103.41% |
| Sep 30, 2024 | -440.70% |
| Jun 30, 2024 | -362.84% |
| Mar 31, 2024 | -582.83% |
| Dec 31, 2023 | -745.11% |
| Sep 30, 2023 | -533.40% |
| Jun 30, 2023 | -912.49% |
| Mar 31, 2023 | -417.72% |
| Dec 31, 2022 | -675.89% |
| Sep 30, 2022 | -747.26% |
| Jun 30, 2022 | -614.08% |
| Mar 31, 2022 | 1,055.00% |